Clinical trials
Completed Phase 2 Mycoses trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2018 | 3 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Astellas Pharma Inc | 1 |
| Blueberry Therapeutics | 1 |
| Ciceri Fabio | 1 |
| Cttq | 1 |
| Fundació Sant Joan de Déu | 1 |
| Gilead Sciences | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mycoses | 23 |
| Aspergillosis | 4 |
| Leukemia | 4 |
| Invasive Fungal Infections | 3 |
| Candidemia | 2 |
| Candidiasis, Invasive | 2 |
| Communicable Diseases | 2 |
| Invasive Pulmonary Aspergillosis | 2 |
| Myelodysplastic Syndromes | 2 |
| Rare Diseases | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.